Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2025-12-26 @ 3:03 AM
Study NCT ID:
NCT03567720
Status:
UNKNOWN
Last Update Posted:
2023-06-01
First Post:
2018-06-13
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC
Sponsor:
OncoSec Medical Incorporated
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-10-11
Start Date Type:
ACTUAL
Primary Completion Date:
2024-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-09
Completion Date Type:
ESTIMATED
First Submit Date:
2018-06-13
First Submit QC Date:
None
Study First Post Date:
2018-06-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-30
Last Update Post Date:
2023-06-01
Last Update Post Date Type:
ACTUAL